South Africa processes 5.1 million HIV CD4, viral load (VL), and tuberculosis (TB) tests annually. This pilot non-randomized trial in South Africa explored an intervention ("MatlaMobile") to deliver laboratory results via mobile phone. Adults completing CD4, VL, and/or TB laboratory tests were enrolled-either receiving results by returning to clinic (control, n = 174) or mobile phone (intervention, n = 226). Study staff instructed control participants to return within 6 days (standard-of-care). MatlaMobile instructed intervention participants with clinically actionable results requiring intervention or treatment change (i.e., < 200 CD4 cells per milliliter, ≥ 400 viral copies per milliliter, or TB positive) to return immediately. A greater proportion of intervention participants than controls saw their results within 7 days of enrollment (73% vs. 8.6%, p < 0.001). Among participants instructed to return, more intervention participants (20%, n = 14/70) returned than controls (8.6%, n = 15/174, p = 0.02). MatlaMobile demonstrated that patients can quickly receive and respond appropriately to digital delivery of health information.

中文翻译：

---

将与HIV相关的结核病实验室结果安全传送到患者手机：一项比较试验研究。

南非每年处理510万艾滋病毒CD4，病毒载量（VL）和结核病（TB）测试。这项在南非的非随机试验性试验探索了一种干预措施（“ MatlaMobile”），可通过手机提供实验室结果。纳入完成CD4，VL和/或TB实验室检查的成年人-通过返回诊所（对照组，n = 174）或通过手机（干预，n = 226）获得结果。研究人员指示对照参与者在6天内返回（标准护理）。MatlaMobile指示干预参与者具有需要干预或治疗改变的临床可行结果（即，每毫升<200 CD4细胞，每毫升≥400病毒拷贝或TB阳性），必须立即返回。入组后7天内，与对照组相比，干预参与者的观察结果比例更高（73％对8.6％，p <0.001）。在被指示要返回的参与者中，干预参与者（20％，n = 14/70）比对照组（8.6％，n = 15/174，p = 0.02）多。MatlaMobile证明，患者可以快速接收健康信息并对其做出适当的数字响应。